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AbstrAct:
Limbal epithelial stem cell (LSC) deficiency is severe disease of the anterior eye surface, causing 
corneal opacification and significant vision loss in the affected patients. Treatment of such patients by 
corneal graft is ineffective due to the fact that corneal donor tissue cannot survive in the eye with-
out LSC. One of possible treatment options is to provide LSC from the other, unaffected eye, and 
to perform corneal graft later on, as a second procedure. In this paper, we have evaluated the visual 
outcome and clinical improvement in three eyes receiving ex vivo cultivated limbal epithelial stem 
cell graft to treat their limbal stem cell deficiency (LSCD) caused by corneal burn. We aimed at de-
termining whether this treatment alone might provide sufficient visual improvement to avoid corneal 
grafting as a second surgery.
Keywords: corneal burn, limbal stem cell deficiency, ex vivo cultivation of limbal stem cells, corneal 
transplantation
Sažetak:
Nedostatak limbalnih matičnih stanica rožnice je teška bolest prednje površine oka koja uzrokuje 
značajan pad vida radi zamučenja rožnicw. Liječenje takovih bolesnika transplantacijom rožnice nije 
moguće jer donorsko rožnično tkivo ne može preživjeti ukoliko nema limbalnih matičnih stanica 
rožnice koje su zadužene za obnovu epitela rožnice. Mogućnost liječenja takvih bolesnika sastoji se u 
tome da se prvo obnove limbalne matične stanice presadbom stanica sa kontralateralnog zdravog oka, 
a kasnije kao sekundarna kirurška procedura može se učiniti transplantacija rožnice. U ovom radu 
istraživali smo oporavak vida i kliničko poboljšanje u tri bolesnika sa opekotinama prednje površine 
oka koji su radi nedostatka limbalnih matičnih stanica rožnice primili presadak ex vivo uzgojenih 
limbalnih stanica koje su kultivirane iz uzorka dobivenog sa njihovog drugog, zdravog oka. Želja 
nam je bila ustvrditi dali sama presadba matičnih stanica može dovesti do dovoljnog oporavka vida i 
prednje površine oka kako drugi zahvat, transplantacija rožnice, nebi niti bio potreban.
ključne riječi: opekotina rožnice, nedostatak limbalnih matičnih stanica rožnice, ex vivo kultivaci-
ja limbalnih stanica, transplantacija rožnice
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introduction
According to the World Health Organization, corneal blindness 
is the fourth leading cause of blindness globally. The impact of 
corneal blindness is huge, since it tends to affect younger people. 
Corneal transplantation may restore vision in many corne-
al diseases, however in case of corneal burns in which limbal 
epithelial stem cells (LSC) are destroyed corneal transplantation 
is not feasible. Only renewal of the corneal epithelium, through 
replacement of the limbal epithelial stem cell population may 
bring long term visual improvement. LSCs are situated at the 
corneo-scleral junction in an area known as the limbus. They 
share common features with other adult somatic stem cells 
including small size, high nuclear to cytoplasmic ratio, high 
proliferative potential, clonogenicity, multipotency, expression of 
stem cell markers such as p63; but lacking expression of differen-
tiation markers such as cytokeratin 3 and 12. The transcription 
factor p63 is required for formation of epidermis and has been 
proposed as a putative positive LSC marker1.
Limbal epithelial stem cell deficiency (LSCD) most often occurs 
due to the corneal burn caused by alkali or acid injury of the 
anterior eye surface. Dependent on the severity of injury, only 
partial or total LSCD may happen. Total LSCD is clinically 
characterized by growth of conjunctival tissue over the cornea, 
corneal neovascularization and opacification. For centuries, 
patients with total LSCD caused by corneal burns were untreat-
able. Then a surgical approach was applied in which a grafting of 
limbal auto- or allo-graft was done combined with corneal graft-
ing to supply a source of LSC2,3. In such cases a larger amount of 
tissue had to be collected either from a contralateral healthy eye, 
thus carrying a risk of damage to healthy eye; or, if LSC graft was 
provided from allogenic tissue a risk from side effects of long-
term immunosuppression was present4-6. Two decades ago, first 
results of successful cultivation of smaller sample of LSC harvest-
ed from the contralateral healthy eye and amplified in number by 
ex vivo cultivation, followed by their transplantation in human 
eye were reported7-9. Since that time different carriers for LSC 
cultivation have been tried in vitro, and their efficacy was tested 
in a clinical setting5, 10, 11. 
MaterialS and MethodS
Two patients with total, and one patient with partial LSCD were 
included in the study. Samples of LSC for ex vivo cultivation 
were obtained from a 1 mm2 biopsy taken from the limbus of the 
contralateral healthy eye under topical anaesthesia. 
cultivation of lSc 
All procedures regarding preparation of amniotic membrane as 
a carrier for LSC and cell cultures were made in aseptic condi-
tions of clean room facility for cell cultures (class A and B of air 
cleanness). Amniotic membranes were prepared from human 
placenta obtained from healthy woman during caesarean section, 
according to established procedure12. After disinfection with 
5% ABAM solution and DPBS, each sample was incubated in 
0.05% enzyme trypsin/1mM EDTA solution. Human limbal 
cells are counted and seeded in 2:1 ratio to previously prepared 
mice fibroblast nutrient layer. Media is changed every third day 
till 80% confluence, when cells are counted. Cell cultures are 
regularly monitored by optical microscopy for their viability. Im-
munocytochemical method and confocal microscopy is used to 
test cells for the presence of stem-cell marker p63 and differentia-
tion marker cytokeratin 313.  
Clinical application of ex vivo expanded epithelial cells 
After LSC cultivation, and once the appropriate number and 
percentage of p63 positive cells is achieved ex vivo, LSC on am-
niotic membrane as a carrier were transferred to corneal surgeon 
for clinical application. Surgeries were done under local anaes-
thesia. Limbal peritomy was performed and fibrovascular pannus 
was carefully dissected from the cornea in all 360o. The amniot-
ic-membrane carrying cultivated LSC were then gently placed 
on the prepared corneal bed with LSC facing toward the cornea. 
Perilimbal region of 3-4 mm bare sclera is also covered with LSC 
sheet and the border of the amniotic membrane is sutured to 
the adjacent conjunctiva with resorptive 8.0 suture. The eyelids 
were kept closed for one week. Post-operatively, patients received 
2-week systemic treatment with amoxicillin (500 mg tid) and 
1-month systemic prednisone (24 mg) and ranitidine with grad-
ual decrease of dosage. Topical steroid and antibiotic drops, and 
frequent artificial drops are started at day 14 after surgery, to pre-
vent damage to the graft with lid manipulation. Throughout the 
postoperative follow-up, operated eyes were controlled for the 
regular epithelialization, decrease of corneal neovascularization 
and improvement of vision. Once the ocular surface becomes 
regular, improvement of vision was tested in order to determine 
whether patient is cured by LSC alone or second surgery – cor-
neal transplantation (CT) is needed. 
results
The preoperative clinical appearance of the eyes treated for 
limbal stem cell deficiency is represented in Figure 1. From their 
contralateral eye LSC samples were taken for ex vivo cultivation. 
Limbal stem cells cultured ex vivo fully covered their carrier, the 
amniotic membrane, between 10 to 14 days after the beginning 
of cultivation process. Testing of their quantity, morphology 
and viability was performed by optical microscopy; the uniform 
layer of stem cells is represented in Figure 2. To check whether 
cultivated cells are indeed stem cells, the presence and quantity 
of LSC differentiation marker p63 was measured. In Figure 3. 
immunofluorescence analysis of p63 and cytokeratin 3 (CK3) 
markers on cells cultured on fibrin, intact amniotic membrane 
and denuded amniotic membrane are represented. Expression of 
stem cell marker p63, and lacking expression of differentiation 
marker CK3 proved that the cultured cells were LSC and such 
cells were issued to surgeon for clinical application.
Patients with LSCD received LSC auto-graft cultivated ex vivo 
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and the clinical outcome regarding regeneration of their anterior 
surface and visual improvement was tested. As shown in Figure 
4, patient with total LSCD caused by tear gas burn reached post-
operative visual acuity of 60% at 6-months after surgery, increas-
ing to 100% vision at 1 postoperative year. His cornea became 
completely transparent and epithelialized with tiny vessels at the 
limbus of the cornea and remained stable for 2 postoperative 
years. Patient with partial LSCD caused by alkali burn obtained 
postoperative vision of 55% at 6 and 85% at 1 year, with normal 
appearance of the anterior eye segment (Figure 5). Only in one 
case with total LSCD caused by explosive wound, grafted limbal 
stem cells did not provide significant visual recovery (from light 
perception preoperatively to 10% postoperatively at 1 postopera-
tive year); and clearance of the cornea was not fully achieved due 
to the fact that the patient had completely abnormal lid function 
causing constant inflammation and abnormal tear film at the 
anterior eye segment (Figure 6). 
diSScuSion
In case of LSC deficiency normal corneal epithelial homeo-
stasis is disrupted and this may occur as a result of primary or 
acquired insults. Deficiency of the LSC may be partial or total 
14,15. The leading cause of total LSC deficiency are corneal burns 
with chemical or thermal substances and corneal diseases such 
as aniridia and Stevens Johnson syndrome. As a result of LSCD, 
conjunctivalization, neovascularisation, chronic inflammation, 
recurrent erosions, ulceration and stromal scarring can occur 
causing painful vision loss2,16. Conventional corneal transplan-
tation has been unsuccessfully tried in such cases, since donor 
cornea cannot survive in a “milieu” where no LSC are present. 
First successful attempt to grow ocular surface epithelial cells in 
a culture for consequent use as grafts, was made in a mice model 
17-19. Twenty years ago, Pellegrini et al. have reported first suc-
cessful epithelialization of a burned human cornea treated with 
a novel approach – transplantation of ex vivo expanded LSC. 
Normal corneal differentiation in vitro was tested with a specific 
biochemical marker, and then the cells were grafted onto the 
burned eye. Successful re-epithelialization of the corneal surface 
was achieved in a 2-year 
follow-up7,8. These results 
provided a new perspective 
on the treatment of ocular 
disorders characterised by 
stem-cell deficiency. Cul-
tured LSC therapy has been 
further developed by several 
investigators using different 
protocols and carriers - 
mostly amniotic membrane 
or fibrin, in the presence or 
absence of growth arrest-
ed 3T3 fibroblast feeder 
layers20,21. After those first 
findings many groups 
around the globe have con-
tinued to treat patients with 
LSC deficiency with ex vivo 
expanded limbal stem cells 
on different carriers such as 
amniotic membrane, fibrin 
or contact lens22-25. The 
most widely used ones in 
Figure 1. Appearance of the eyes with limbal epithelial stem cell deficiency caused by corneal burn.
Figure 2. Electronic microscopy image of limbal epithelial 
cells cultured ex vivo on the amniotic membrane.
Figure 3. Immunofluorescence analysis of p63 (a, b, c) and CK3 (d, e, f ) markers of limbal epithelial stem cells and differentiated limbal 
cells, cultured on fibrin (a, d), intact amniotic membrane (I.A.M.) (b, e) and denuded amniotic membrane (D.A.M.) (c, f ) respectively. 
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clinical work today are fibrin and amniotic membrane, although 
other potential carriers are also tested. Same methodology is 
theoretically applicable for patients with bilateral corneal burns, 
when LSC allografts obtained from a relative or unrelated donor 
are used; however, with much lower success rate and a negative 
impact of aggressive systemic immunosuppressive treatment. 
The effort is also made to grow LSC in a media completely free 
of any animal-derived products, and successful clinical results 
of such technique, using only autologous human serum as the 
only growth supplement are already reported26, 27. Later on, oral 
mucosal epithelial cell and mesenchymal stem cell grafts have 
been tried, which is of special interest in cases of bilateral corneal 
burns where autologous grafts from the other healthy eye can’t be 
obtained28-31. The transplantation of bioengineered oral mucosal 
epithelium is also a good strategy in bilateral LSC deficiency; 
however further studies are required to optimize the culture 
conditions and visual outcome32. 
Figure 4. Preoperative image of an eye with total limbal stem cell deficiency caused by tear gas burn (upper left); and postoperative image at 1 year (upper 
right) and 2 years (lower left) after transplantation of ex vivo cultivated limbal epithelial stem cells. Visual acuity improved from preoperative value of light 
perception to 100% postoperatively.
Figure 5. Preoperative image of an eye with partial limbal stem cell deficiency caused by alkali burn, and 1year postoperative appearance of the eye treated 
with ex vivo cultivated limbal epithelial stem cells. Visual acuity improved from preoperative value of 15% to 85% at 1 year postoperatively.
In our clinical study on cases with unilateral total and partial 
LSCD we have investigated whether transplantation of limbal 
stem cells alone (without subsequent corneal graft) may restore 
normal anterior surface and adequately improve vision. On 
this small number of eyes, we have seen that in case of normal 
lid morphology and function patients had total visual recovery 
and normal anterior surface and did not need another surgery 
– corneal graft. In one case of serious lid abnormality caused 
by explosive wound significant improvement in both anterior 
surface and visual acuity was achieved after one year, however 
another surgery in form of corneal graft may be needed for full 
visual recovery. If the disease is bilateral, other autologous stem 
cells, such as oral mucosal cells, orbital fat cells and mesenchymal 
stem cells, might be an option. Recent data from literature, ana-
lysing overall published results on LSCD treatment have shown 
that an “older” approach of grafting limbal stem cells from a 
healthy eye without their amplification ex vivo may be equally 
Figure 6. Preoperative image of an eye with total limbal stem cell deficiency and lid abnormality (a) caused by explosive burn and postoperative image at 2 
years after transplantation of ex vivo cultivated limbal epithelial stem cells (b). Visual acuity improved from preoperative value of light perception to 10% 
postoperatively.
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good, or even superior option of treatment33. In our opinion, 
since a larger stem cell graft has to be excised from a healthy eye 
with this approach, it is still questionable whether this may have 
consequences in a long run.
concluSion:
In case of limbal stem cell deficiency (LSCD) best source of LSC 
is from the other uninjured eye with their multiplication by ex 
vivo cultivation. In eyes with normal lid function vision can be 
significantly improved by LSC graft alone, without any further 
need for subsequent corneal graft, which is not the case if serious 
lid abnormality is present.
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